Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

COVID-19 Is Back! The JN.1 variant is spreading rapidly across Asia: How COVID vaccines have prevented the past variants and ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.

Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...

Subunit vaccines isolate a portion of the microbe instead of the entire bug to create the immune response. Hepatitis B and ...

The RNP complex is the influenza virus’s essential package, the virus’s blueprints and a copy machine all rolled in one. The ...

An article published on a medical website Medscape Today was entitled “Minnesota Bill Against Vaccines Promotes ...